Prostaglandin E1 and arterial occlusive disease: pharmacological considerations
Open Access
- 1 December 1988
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 18 (6), 549-554
- https://doi.org/10.1111/j.1365-2362.1988.tb01266.x
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- The prostacyclin analogue iloprost and prostaglandin E1 suppress sterol synthesis in freshly isolated human mononuclear leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Stimulus-dependent inhibition of superoxide generation by prostaglandinsClinical Immunology and Immunopathology, 1985
- Efficacy of prostaglandin E in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive diseaseJournal of Vascular Surgery, 1984
- Metabolic disposition of prostaglandin E1 in manBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1Prostaglandins and Medicine, 1981
- Endogenous levels of 15-keto-dihydro-prostaglandins in human plasma: Parameters for monitoring prostaglandin synthesisBiochemical Medicine, 1974
- Relationship between chemical structure and plateletaggregation activity of prostaglandinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- Effect of Prostaglandin E1on Forearm Blood FlowScandinavian Journal of Clinical and Laboratory Investigation, 1969
- Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in manLife Sciences, 1968
- Weitere Untersuchungen über Prostaglandin, die physiologisch aktive Substanz gewisser Genitaldrüsen1Skandinavisches Archiv Für Physiologie, 1939